GlassScriptPhysician profile
Timothy A Walline
NPI 1114925294
$5,354.55
in general payments reported to CMS, 2019-2025
18 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $942 · 2021: $124 · 2022: $447 · 2023: $568 · 2024: $1,466 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,092 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,091.59 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,255.60 | 2019-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $409.53 | 2023-2025 | Envista Mx60 Iol, Stellaris, Envista Envy Iol |
| Mallinckrodt Hospital Products INC. | $199.35 | 2023-2024 | Acthar |
| Harrow Eye, LLC | $78.64 | 2024-2025 | Iheezo, Triesence, Flarex |
| Alimera Sciences, INC. | $58.76 | 2023-2024 | Iluvien, Yutiq |
| Glaukos Corporation | $54.43 | 2019 | |
| Ani Pharmaceuticals, INC. | $46.57 | 2025 | Purified Cortrophin Gel, Iluvien |
| Kala Pharmaceuticals, INC. | $44.67 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $40.32 | 2024 | Iolmaster 700 |
| Regeneron Healthcare Solutions, INC. | $33.19 | 2024 | Eylea |
| Novartis Pharmaceuticals Corporation | $29.63 | 2019-2021 | |
| Genentech USA, INC. | $26.47 | 2025 | Vabysmo |
| Amgen INC. | $19.48 | 2025 | Tepezza |
| Rxsight INC | $15.49 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Coopervision INC. | $14.90 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $14.32 | 2025 | |
| Rayner Intraocular Lenses Limited | $13.20 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Walline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.